1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 4-ethoxy-3-phenylsulfonylfuroxan in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (4-ethoxy-3-phenylsulfonylfuroxan) | Trials (4-ethoxy-3-phenylsulfonylfuroxan) | Recent Studies (post-2010) (4-ethoxy-3-phenylsulfonylfuroxan) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 8 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergamaschi, M; Bongrani, S; Caruso, P; Civelli, M; Gasco, A; Giossi, M; Razzetti, R | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 4-ethoxy-3-phenylsulfonylfuroxan
| Article | Year |
|---|---|
The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Aorta; Cyclic GMP; Dose-Response Relationship, Drug; Humans; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Oxadiazoles; Phosphodiesterase Inhibitors; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1996 |